Julie Delyon

Experience in daily practice with ipilimumab for the treatment of patients with metastatic melanoma: an early increase in lymphocyte and eosinophil counts is associated with improved survival

Julie Delyon, Céu Mateus, D. Lefeuvre et al. · Annals of Oncology · 2013 · 309 citations · Full text

Life Sciences, Immunology, Oncology +16

Late-onset and long-lasting immune-related adverse events from immune checkpoint-inhibitors: An overlooked aspect in immunotherapy

Eleonora Ghisoni, Alexandre Wicky, Hasna Bouchaab et al. · European Journal of Cancer · 2021 · 186 citations · Full text

Life Sciences, Immunology, Oncology +16

STAT3 Mediates Nilotinib Response in KIT-Altered Melanoma: A Phase II Multicenter Trial of the French Skin Cancer Network

Julie Delyon, Sylvie Chevret, Thomas Jouary et al. · Journal of Investigative Dermatology · 2017 · 58 citations · Full text

Medicine, Oncology, Pharmacology +17

Management of Kaposi sarcoma after solid organ transplantation: A European retrospective study

Julie Delyon, Clémentine Rabaté, Sylvie Euvrard et al. · Journal of the American Academy of Dermatology · 2019 · 57 citations · Full text

Medicine, Oncology, Surgery +16

Acquired generalized lipodystrophy under immune checkpoint inhibition

N. Haddad, Tiphaine Vidal-Trécan, Barouyr Baroudjian et al. · British Journal of Dermatology · 2019 · 53 citations

Life Sciences, Immunology, Oncology +17